Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date ICMJE | July 27, 2012 | ||||
Last Updated Date | July 30, 2012 | ||||
Start Date ICMJE | August 2012 | ||||
Estimated Primary Completion Date | August 2014 (final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE | |||||
Original Primary Outcome Measures ICMJE | |||||
Change History | Complete list of historical versions of study NCT01654471 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures ICMJE | |||||
Original Secondary Outcome Measures ICMJE | |||||
Current Other Outcome Measures ICMJE | |||||
Original Other Outcome Measures ICMJE | |||||
Descriptive Information | |||||
Brief Title ICMJE | Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease | ||||
Official Title ICMJE | Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease | ||||
Brief Summary | The aim of the study is to validate the Korean version of Walking Impairment Questionnaire in patients with peripheral arterial occlusive disease. |
||||
Detailed Description | First, the original version of WIQ will be translated into Korean, then it will be translated into English, again. The translated version will be sent to the original author to compare with the original version. After correcting, the Korean version will be completed. The patients with peripheral arterial disease will fill in the Korean version of WIQ before starting treatments. Baseline results of arterial function test, toe-brachial index and treadmill test will be recorded. Three months later, the patients will complete the questionnaire again. Arterial function test, toe-brachial index and treadmill test also will be taken again after treatment and the correlation of WIQ and other exams will be evaluated. |
||||
Study Type ICMJE | Observational | ||||
Study Design ICMJE | Observational Model: Case-Only Time Perspective: Prospective |
||||
Biospecimen | |||||
Sampling Method | Probability Sample | ||||
Study Population | Patients with peripheral arterial disease |
||||
Condition ICMJE | Peripheral Arterial Occlusive Disease | ||||
Intervention ICMJE | |||||
Study Group/Cohort (s) |
|
||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Not yet recruiting | ||||
Estimated Enrollment ICMJE | 50 | ||||
Estimated Completion Date | August 2014 | ||||
Estimated Primary Completion Date | August 2014 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 19 Years to 80 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts ICMJE |
|
||||
Location Countries ICMJE | Korea, Republic of | ||||
Administrative Information | |||||
NCT Number ICMJE | NCT01654471 | ||||
Other Study ID Numbers ICMJE | WIQ-SNU | ||||
Has Data Monitoring Committee | Yes | ||||
Responsible Party | Seung-Kee Min, Seoul National University Hospital | ||||
Study Sponsor ICMJE | Seoul National University Hospital | ||||
Collaborators ICMJE | Astellas Pharma Korea, Inc. | ||||
Investigators ICMJE | |||||
Information Provided By | Seoul National University Hospital | ||||
Verification Date | July 2012 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |